RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
ValenzaBio Inc antibody for inflammatory eye disease Series A USD 70,000,000
Blossomhill Therapeutics Inc Biotechnology company focused on oncology and autoimmune disorders. Series A USD 71,000,000
Perfect Day Inc Series C USD 140,000,000
Quell Therapeutics Ltd Developer of engineered T regulatory cell therapies. Series A GBP 35,000,000
Aquaro Histology Inc Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory. Series A USD 9,810,879
3SBio Inc IPO HKD 5,510,000,000
Wyeth Pharmaceuticals Acquisition USD 68,000,000,000

MOST ACTIVE ACQUIRERS

Pfizer Inc US 1

BEST FUNDED


Biotechnology company focused on oncology and autoimmune disorders.

Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory.

Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies.

Developer of engineered T regulatory cell therapies.

Biotechnology company developing a new class of therapies for metabolic diseases and disorders.

antibody for inflammatory eye disease